Home » Topics » Briefs » Other news to note

Other news to note
RSS

Genaera to sell remaining proprietary assets

Jan. 15, 2010

Pharmaxis acquires Topigen

Jan. 15, 2010

AnaptysBio and Roche sign agreement for development of novel antibody therapeutics

Jan. 15, 2010

Sciele Pharma changes company name to Shionogi Pharma

Jan. 15, 2010

Alnylam provides key goals for next 18 months

Jan. 15, 2010

Sangamo initiates phase IIb trial of SB-509 in DN and phase I trial of CTL product in GM

Jan. 14, 2010

Inverness offers to acquire up to 75.79% of Standard Diagnostics' issued shares

Jan. 14, 2010

ReNeuron presents regulatory update on ReN-001 and ReN-009 stem cell therapies

Jan. 13, 2010

Ablynx generates Nanobodies against an ion channel and CXCR4 receptor

Jan. 13, 2010

Ensemble Discovery initiates collaboration with Pfizer

Jan. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...